Proposal of modification for the definition of genetic heterogeneity in HER2 testing in breast cancer

Archives of Pathology and Laboratory Medicine

Volumn 134, Issue 2, 2010, Pages 162-

  Hsu, Chih Yi ^a,b   Li, Yanna Yfen Yau ^a,b   Yang , Ching Fen ^a,b   Ho, Donald Ming Tak ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; HER2 PROTEIN, HUMAN;

BREAST TUMOR; FEMALE; GENE AMPLIFICATION; GENETIC HETEROGENEITY; GENETICS; HUMAN; LETTER;

BREAST NEOPLASMS; FEMALE; GENE AMPLIFICATION; GENETIC HETEROGENEITY; HUMANS; RECEPTOR, ERBB-2;

EID: 76449086944     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. Vance GH, Barry TS, Bloom KJ, et al. Genetic heterogeneity in HER2 testing in breast cancer: panel summary and guidelines. Arch Pathol Lab Med. 2009;133(4):611-612.
2. Wolff AC, Hammond EH, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists Guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007;25(1):118-145.
3. Wolff AC, Hammond EH, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists Guideline recommendation for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med. 2007;131(1):18-43.